Fundraising FoxKdT Ventures — 2020 Investments
7 investments dated 2020 · listed companies and verified rows first · show all
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Board seatCain McClary· per SEC Form D
Co-investorsBios PartnersConnecticut InnovationsLeaps by Bayer
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in
Board seatAndrew Cain McClaryCain McClary· per SEC Form D
Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesPlug and Play VenturesViking GlobalBuilders VC+5 more
Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in
Co-investorsaMoonLuma GroupSanofi VenturesInnovation EndeavorsCantos VenturesCatalio Capital Management, LP+5 more
Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing.
BiotechHealthtechMedical DevicesNew MaterialsChicago, US
Caralynn Nowinski Collens(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Co-founder & CSO)Adam Jakus(Co-Founder)inRamille S.(Founder)inLarry Weinstein(SVP, Manufacturing & Quality Operations)
Co-investorsAlumni VenturesBetter Ventures Central LlcGaingelsHarvard Business Angels of ChicagoHAWKTAILLofty Ventures+5 more
.png)
__Twitter.png)
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.
AI & Machine LearningBiotechDigital HealthSan Carlos, US
Akshay Nanduri(Founder)inSalmaan Ahmed(Executive Officer)Jonathan Fleming(Director)
Co-investors515 VenturesLifeX VenturesBlue Venture FundsDigitalis Ventures
Remedy Robotics develops a robotic telesurgery approach for treating stroke and other cardiovascular conditions remotely, aiming to raise the standard of care across the cardiovascular continuum.
AI & Machine LearningHealthtechMedical DevicesRoboticsSan Francisco, US
David Bell(Founder)Jake Sganga(Founder)
Co-investorsDCVC (Data Collective)7percent VenturesBlackbird VenturesDivergent CapitalPathbreaker Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Circularis Biotechnologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.